On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances

Prostate cancer (PC) is a leading cause of morbidity and mortality among men worldwide. Molecular biomarkers work in conjunction with existing clinicopathologic tools to help physicians decide who to biopsy, re-biopsy, treat, or re-treat. The past decade has witnessed the commercialization of multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yiwu, Yeon, Su Yeon, Qian, Chen, You, Sungyong, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703658/
https://www.ncbi.nlm.nih.gov/pubmed/34948334
http://dx.doi.org/10.3390/ijms222413537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703658/
https://www.ncbi.nlm.nih.gov/pubmed/34948334
http://dx.doi.org/10.3390/ijms222413537

Ejemplares similares